Skip Navigation LinksHome > April 2014 - Volume 114 - Issue 4 > FDA Lifts Restrictions on Rosiglitazone
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000445681.44930.17
Drug Watch

FDA Lifts Restrictions on Rosiglitazone

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* The Food and Drug Administration has lifted many of the restrictions it had placed on the type 2 antidiabetic drug rosiglitazone (Avandia) in 2011.

* Reevaluation of data from a major clinical trial indicated that rosiglitazone did not increase the risk of cardiovascular events as had been previously suggested.

© 2014 Lippincott Williams & Wilkins. All rights reserved.

Login